THC Biomed Intl Yönetim

Yönetim kriter kontrolleri 0/4

Anahtar bilgiler

John Miller

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	9.1yrs
CEO sahipliği	19.1%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	8.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

John Miller'un ücretlendirmesi THC Biomed Intl'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Apr 30 2023	n/a	n/a	-CA$4m
Jan 31 2023	n/a	n/a	-CA$3m
Oct 31 2022	n/a	n/a	-CA$3m
Jul 31 2022	n/a	n/a	-CA$3m
Apr 30 2022	n/a	n/a	-CA$3m
Jan 31 2022	n/a	n/a	-CA$4m
Oct 31 2021	n/a	n/a	-CA$6m
Jul 31 2021	n/a	n/a	-CA$6m
Apr 30 2021	n/a	n/a	-CA$6m
Jan 31 2021	n/a	n/a	-CA$5m
Oct 31 2020	n/a	n/a	-CA$2m
Jul 31 2020	n/a	n/a	-CA$162k
Apr 30 2020	n/a	n/a	-CA$4m
Jan 31 2020	n/a	n/a	-CA$8m
Oct 31 2019	n/a	n/a	-CA$13m
Jul 31 2019	CA$67k	CA$60k	-CA$13m
Apr 30 2019	n/a	n/a	-CA$12m
Jan 31 2019	n/a	n/a	-CA$7m
Oct 31 2018	n/a	n/a	-CA$12m
Jul 31 2018	CA$67k	n/a	-CA$12m
Apr 30 2018	n/a	n/a	-CA$10m
Jan 31 2018	n/a	n/a	-CA$11m
Oct 31 2017	n/a	n/a	-CA$1m
Jul 31 2017	CA$66k	CA$60k	-CA$605k

CEO

John Miller

9.1yrs

Görev süresi

CA$66,750

Tazminat

Mr. John Miller serves as Chief Executive Officer at THC Biomed Intl Ltd. since April 29, 2015. He is also President at THC Biomed Intl Ltd.and its Director since June 3, 2014. He was Director and Office...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
John Miller	President	9.9yrs	CA$66.75k	19.14% CA$ 627.5k
Jung Hee	Co-Founder	9.9yrs	CA$66.66k	9.89% CA$ 324.2k
Jason Springett	Member of Advisory Board	8.8yrs	Veri yok	Veri yok
Donald Shaxon	Member of Advisory Board	8.8yrs	Veri yok	Veri yok
Ashish Dave	Independent Director	6.9yrs	CA$6.50k	Veri yok
Penelope Laine	Independent Director	4.2yrs	Veri yok	0.0061% CA$ 200.0

8.8yrs

THC Biomed Intl Yönetim

Yönetim kriter kontrolleri 0/4

Anahtar bilgiler

Son yönetim güncellemeleri

Insufficient new directors

THC Biomed Intl Ltd. Announces Laine Temporarily Resigns as Director of the Company

Recent updates

New minor risk - Financial data availability

THC Biomed Intl Ltd. to Report Q1, 2024 Results on Feb 05, 2024

THC Biomed Intl Ltd. Introduces Always Hi New Brand Catering to Maturing Cannabis Consumer Trends

Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?

Thc Biomed Intl Ltd. Launches New Summer Cannabis Product: Thc Kiss Strawberry Tangerine Gummies

Third quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.001 loss in 3Q 2022)

Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?

Second quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.009 loss in 2Q 2022)

Insufficient new directors

Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?

First quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0 in 1Q 2022)

Full year 2022 earnings released: CA$0.019 loss per share (vs CA$0.039 loss in FY 2021)

Is THC Biomed Intl (CSE:THC) Using Too Much Debt?

Third quarter 2022 earnings released: CA$0.001 loss per share (vs CA$0.008 loss in 3Q 2021)

Forecast to breakeven in 2023

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

We Think THC Biomed Intl (CSE:THC) Has A Fair Chunk Of Debt

THC BioMed Intl Ltd. Announces Availability of THC KISS Cannabis Biscuits to Consumers Through Ontario Cannabis Store Online and Wholesale to Ontario Retail Stores

Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?

No longer forecast to breakeven

THC BioMed Intl Ltd. Announces Three New Products to be List and Sold through Ontario Cannabis Stores

THC BioMed Announces Shipment of THC KISS Cannabis Biscuits to BC Cannabis Stores

THC Biomed Intl Ltd. announced that it has received CAD 0.5 million in funding

Forecast to breakeven in 2022

Is THC Biomed Intl (CSE:THC) Using Too Much Debt?

Analysts Expect Breakeven For THC Biomed Intl Ltd. (CSE:THC) Before Long

Second quarter 2021 earnings released: CA$0.018 loss per share (vs CA$0.001 profit in 2Q 2020)

THC BioMed Intl Ltd. Ships THC Kiss Gummies to the Province of B.C

New 90-day high: CA$0.26

THC Biomed Intl Ltd. Receives Purchase Order for THC Kiss Gummies from the Province of B.C

Would THC Biomed Intl (CSE:THC) Be Better Off With Less Debt?

First quarter 2021 earnings released: CA$0.004 loss per share

THC BioMed Intl Ltd. Launches THC Kiss Gummies in Recreational and Medical Cannabis Markets

Full year 2020 earnings released: CA$0.001 loss per share

THC Biomed Intl Ltd. Announces Laine Temporarily Resigns as Director of the Company

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi